IZBA
IZBA
Approved
DIN Number
02457997
Drug Class
Human
Market Date
Feb 6, 2017
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02457997
AIG Number0145801002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EE04 TRAVOPROST
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:40.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
TRAVOPROSTActive
Strength: 0.003 % / W/V
Monograph: TRAVOPROST